ACCESSION: MSBNK-SMB_Measured-HSA032P0137002
RECORD_TITLE: Annotated; Hypoxanthine; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'RA23-pos_511': {'bp': 3079.0, 'sum': 12325.0}, 'RA13-pos_560': {'bp': 2657.0, 'sum': 11365.0}, 'RA25-pos_1367': {'bp': 2424.0, 'sum': 9852.0}, 'HC17-pos_545': {'bp': 2248.0, 'sum': 11682.0}, 'HC15-pos_1493': {'bp': 1715.0, 'sum': 7723.0}, 'RA11-pos_1225': {'bp': 1501.0, 'sum': 6714.0}, 'HC19-pos_1322': {'bp': 1437.0, 'sum': 6107.0}, 'HC9-pos_517': {'bp': 1268.0, 'sum': 7083.0}, 'QC2-pos_791': {'bp': 1259.0, 'sum': 6248.0}, 'QC7-pos_1284': {'bp': 1178.0, 'sum': 5364.0}, 'RA23-pos_591': {'bp': 1143.0, 'sum': 4350.0}, 'RA5-pos_536': {'bp': 864.0, 'sum': 3804.0}, 'HC1-pos_613': {'bp': 705.0, 'sum': 4368.0}, 'HC9-pos_1329': {'bp': 593.0, 'sum': 2739.0}}
COMMENT: RETENTION_TIME_STDEV 0.667
COMMENT: PRECURSOR_M/Z_RAW 137.045329
COMMENT: PRECURSOR_M/Z_STDEV 0.000398
COMMENT: PRECURSOR_IN_MS1 mz 137.045905; int 459.442; delta(ppm) 7.861226
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 11.453; C3H9N2O2P; [M+H]+; delta(ppm) -11.452631
COMMENT: PROPOSED_MF SevenGoldenRules 0.691; C5H4N4O; [M+H]+; delta(ppm) 0.690980
COMMENT: PROPOSED_MF SevenGoldenRules 10.526; C4H8O5; [M+H]+; delta(ppm) 10.526424
COMMENT: PROPOSED_MF MS-FINDER 4.527; C5H4N4O; [M+H]+; delta(ppm) 0.684362
COMMENT: PROPOSED_MF MS-FINDER 3.269; C3H9N2O2P; [M+H]+; delta(ppm) -11.368164
COMMENT: PROPOSED_MF MS-FINDER 3.196; C4H8O5; [M+H]+; delta(ppm) 10.443348
COMMENT: PROPOSED_MF MS-FINDER 2.678; C5H12S2; [M+H]+; delta(ppm) 4.102185
COMMENT: PROPOSED_MF SIRIUS5_Sirius 28.075; C5H4N4O; [M+H]+; delta(ppm) 0.684362
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.738; C4H8O5; [M+H]+; delta(ppm) 10.443348
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.872; C5H12S2; [M+H]+; delta(ppm) 4.102185
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H4N4O; [M+H]+; delta(ppm) 0.684362
COMMENT: PROPOSED_MF SIRIUS6_Sirius 46.633; C5H4N4O; [M+H]+; delta(ppm) 0.684362
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.538; C3H9N2O2P; [M+H]+; delta(ppm) -11.368164
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.365; C4H9ClN2O; [M+H]+; delta(ppm) -149035.029204
COMMENT: PROPOSED_MF SIRIUS6_Sirius 34.820; C2H5FN4O2; [M+H]+; delta(ppm) -7.653327
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.972; C7H6NO2; [M+H]+; delta(ppm) -9.112739
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.968; C2H7ClN5; [M+H]+; delta(ppm) -149027.934599
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.890; CH7N5OP; [M+H]+; delta(ppm) -1.571108
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.738; C4H8O5; [M+H]+; delta(ppm) 10.443348
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.128; C5H12S2; [M+H]+; delta(ppm) 4.102185
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.827; C5H5F3N; [M+H]+; delta(ppm) 8.730008
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H4N4O; [M+H]+; delta(ppm) 0.684362
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 5.000; FDGQSTZJBFJUBT-UHFFFAOYSA-N; C5H4N4O; HYPOXANTHINE
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; OFCNXPDARWKPPY-UHFFFAOYSA-N; C5H4N4O; Massbank:EQ333605 Allopurinol1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.299; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; O=C1N=CNC2=C1NN=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.273; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; OC1=NC=NC2=C1NC=N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.237; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; OC=1N=CC2=NCN=C2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.203; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; OC1=NC=NC2=C1N=NC2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.960; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; NC1=C(N=CN1C=O)C#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.414; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.597; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; Allopurinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.449; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.429; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.316; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.292; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M+H]+; CNP0439982
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.189; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; CNP0440561
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.172; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M+H]+; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.136; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.044; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.247; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.857; JPIJQSOTBSSVTP-MZTXYVAJNA-N; [M+H]+; Erythronic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.157; FHEQBJDIKIFJTB-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3-(methylperoxy)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.113; IASCKZVQSNCRPV-UHFFFAOYSA-N; [M+H]+; 2,2,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.543; PUUCPZKSTXFGOC-UHFFFAOYSA-N; [M+H]+; Ethyl isopropyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.543; SNGRPWPVGSSZGV-UHFFFAOYSA-N; [M+H]+; Ethyl propyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.525; DPLYGYOSWLFGGY-UHFFFAOYSA-N; [M+H]+; 1-Pentanesulfenothioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.490; QTWVOHZEDPQFTP-MLHKIVSYNA-N; [M+H]+; UNPD3575
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.421; BBYNYNMPOUQKKS-UHFFFAOYSA-N; [M+H]+; 2,2-Bis(methylthio)propane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.369; KMTUBAIXCBHPIZ-UHFFFAOYSA-N; [M+H]+; pentane-1,5-dithiol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M+H]+; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; IASCKZVQSNCRPV-UHFFFAOYSA-N; [M+H]+; 2,2,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.993; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M+H]+; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.988; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M+H]+; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.962; FHEQBJDIKIFJTB-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3-(methylperoxy)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.957; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M+H]+; CNP0440561
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.942; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.935; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.931; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M+H]+; CNP0439982
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.923; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; Allopurinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.914; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.911; JPIJQSOTBSSVTP-MZTXYVAJNA-N; [M+H]+; Erythronic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.908; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.896; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.912; JPIJQSOTBSSVTP-STHAYSLISA-N; [M+H]+; (2R,3S)-2,3,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.877; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M+H]+; 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.398; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M+H]+; 1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.830; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M+H]+; 3-hydroxytriazolo[4,5-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.185; LGSBQUSNSQFXGC-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-2-(2-hydroxyethoxy)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; QBKYWNHLILCGEI-UHFFFAOYSA-N; [M+H]+; 4-cyano-1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M+H]+; 3,7-dihydropurin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M+H]+; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; ZQBWCQHCMJERPW-UHFFFAOYSA-N; [M+H]+; 2-(1,2-dihydroxyethoxy)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.069; DHQDPICNDWFEBQ-UHFFFAOYSA-N; [M+H]+; 5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; GLVYFVYELPFNQC-UHFFFAOYSA-N; [M+H]+; 6H-pyrazolo[5,1-c][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; QICFIUZWDPJRQF-UHFFFAOYSA-N; [M+H]+; 1,6-dihydropyrazolo[3,4-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; QMFPURRPZZSJPF-UHFFFAOYSA-N; [M+H]+; 3H-imidazo[2,1-f][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M+H]+; 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; DSZCQHJBMSIMNX-UHFFFAOYSA-N; [M+H]+; 3,6-dihydroimidazo[4,5-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.018; GXBDCPYXMVITMR-UHFFFAOYSA-N; [M+H]+; 1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; RBWFEMOYMLQPAV-UHFFFAOYSA-N; [M+H]+; 1,5-dihydropyrazolo[3,4-d]pyridazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; JDPCCIANHKTFII-UHFFFAOYSA-N; [M+H]+; 6H-[1,2,4]triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; VNMKCHFGAZFWKI-UHFFFAOYSA-N; [M+H]+; 6H-[1,2,4]triazolo[4,3-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; RDHMBEKEDDDWOF-UHFFFAOYSA-N; [M+H]+; 4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.985; CLGWVBPVZYVPMR-UHFFFAOYSA-N; [M+H]+; 2H-[1,2,4]triazolo[4,3-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; REINGZOTPYBONL-UHFFFAOYSA-N; [M+H]+; [1,2]oxazolo[5,4-d]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; WKOSBXIJGCIJII-UHFFFAOYSA-N; [M+H]+; [1,2]oxazolo[4,5-b]pyrazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.769; GJDZQWVZICYPIT-UHFFFAOYSA-N; [M+H]+; [1,3]oxazolo[5,4-d]pyrimidin-7-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -15.782; FDGQSTZJBFJUBT; [M+H]+; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -32.859; CRIZPXKICGBNKG; [M+H]+; 2-Purinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -60.472; YPDSIEMYVQERLJ; [M+H]+; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.062; JFZSDNLQDTYVEE; [M+H]+; Zyloprim (TN)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -104.823; JDPCCIANHKTFII; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.425; OFCNXPDARWKPPY; [M+H]+; Ailurial
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.735; NYNNJBKGLLSTAZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.074; DHQDPICNDWFEBQ; [M+H]+; AmbscX-046497
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.070; GXBDCPYXMVITMR; [M+H]+; [1,2,4]Triazolo[1,5-a]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.454; CYYQSLSRZGVVHE; [M+H]+; Purine 3-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.416; QBKYWNHLILCGEI; [M+H]+; ACMC-20amkb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.571; AXEBUIBRUVSSHM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.742; FPIRBHDGWMWJEP; [M+H]+; 1-Hydroxy-7-azabenzotriazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.008; OGCXIHWGXUQTCQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.603; FDGQSTZJBFJUBT; [M+H]+; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -15.013; FDGQSTZJBFJUBT; [M+H]+; Sarkin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -47.707; CRIZPXKICGBNKG; [M+H]+; 7H-purin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -69.817; JFZSDNLQDTYVEE; [M+H]+; 7-Hydroxypyrazolo[4,3-d]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.416; QICFIUZWDPJRQF; [M+H]+; 1,6-Dihydropyrazolo[3,4-d]pyridazin-2-ium-7-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.331; YPDSIEMYVQERLJ; [M+H]+; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -106.982; DHQDPICNDWFEBQ; [M+H]+; Pyrazolo[1,5-d][1,2,4]triazin-4(5H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.412; RBWFEMOYMLQPAV; [M+H]+; 1,5-Dihydropyrazolo[3,4-d]pyridazin-2-ium-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.045; ONMSHVSDDXZRPS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.523; NYNNJBKGLLSTAZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.730; RDHMBEKEDDDWOF; [M+H]+; 1,4-Dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-8-ium-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.894; FDGQSTZJBFJUBT; [M+H]+; Sarkin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Hypoxanthine, FDGQSTZJBFJUBT-UHFFFAOYSA-N; Matching to 5 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (10), MetFrag:PubchemLite (3); This structural isomer was suggested from the biological context HMDB HMDB0000157;
CH$NAME: Hypoxanthine
CH$NAME: 3,7-dihydropurin-6-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H4N4O
CH$EXACT_MASS: 136.038511
CH$SMILES: C1=NC2=C(N1)C(=O)N=CN2
CH$IUPAC: InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)
CH$LINK: CHEBI CHEBI:17368
CH$LINK: HMDB HMDB0000157
CH$LINK: INCHIKEY FDGQSTZJBFJUBT-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:790
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.545
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 137.045881
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-029l-5900000000-2086ca427b54c881cbf9
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0297104 292.2543 55.029969 17.8631 139.33 0.7426 14 f{C2H3N2}/11.56ppm,p-C3H2N2O1
  65.0138042 69.7284 65.013974 21.1186 23.63 0.7157 11 f{C3H1N2}/5.84ppm,p-C2H4N2O1
  67.0296767 152.9989 67.029823 21.8112 57.82 0.7567 13 f{C3H3N2}/8.98ppm,p-C2H2N2O1
  81.0718053 75.5133 81.071999 24.6942 50.97 -0.2793 11 ?
  82.0406142 339.3758 82.040812 19.0515 99.41 0.8295 14 f{C3H4N3}/7.81ppm,p-C2H1N1O1
  83.0239948 63.3029 83.024197 12.2374 26.48 0.6237 10 f{C3H3N2O1}/0.07ppm,p-C2H2N2
  92.0250033 155.6820 92.025246 15.9848 55.81 0.5771 13 f{C4H2N3}/7.39ppm,p-C1H3N1O1
  93.0092085 33.7252 93.009456 23.8579 7.83 0.8851 10 f{C4H1N2O1}/9.35ppm,p-C1H4N2
  94.0410375 493.0242 94.041290 13.4835 177.31 0.8022 14 f{C4H4N3}/11.31ppm,p-C1H1N1O1
  110.0359883 796.9681 110.036324 14.2771 164.93 0.8549 14 f{C4H4N3O1}/10.00ppm,p-C1H1N1
  119.0362573 673.9399 119.036644 12.6096 148.75 0.8813 14 f{C5H3N4}/8.69ppm,p-H2O1
  120.0205004 89.7517 120.020893 16.2639 46.73 0.4779 12 f{C5H2N3O1}/10.52ppm,p-H3N1
  137.0465863 999.0000 137.047088 15.0679 50.22 1.0000 14 f{C5H5N4O1}/5.83ppm,p
PK$NUM_PEAK: 13
PK$PEAK: m/z int. rel.int.
  55.029710 292.25 292
  65.013804 69.73 69
  67.029677 153.00 152
  81.071805 75.51 75
  82.040614 339.38 339
  83.023995 63.30 63
  92.025003 155.68 155
  93.009208 33.73 33
  94.041038 493.02 493
  110.035988 796.97 796
  119.036257 673.94 673
  120.020500 89.75 89
  137.046586 999.00 999
//
